<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419804/" ref="ordinalpos=268&amp;ncbi_uid=5143477&amp;link_uid=PMC3419804" image-link="/pmc/articles/PMC3419804/figure/F1/" class="imagepopup">Figure 1. Autophagy and <span class="highlight" style="background-color:">signaling</span> pathways.  From: Autophagy, Myocardial Protection and the Metabolic Syndrome. </a></div><br /><div class="p4l_captionBody">Insulin signaling activates the mTOR pathway via Akt and thus suppresses autophagy. The mTOR inhibitor rapamycin and its derivatives enhance autophagy. The AMPK pathway modulates the mTOR pathway via multiple mechanisms including interaction with Akt, TSC1, mTOR and Ulk1. Biguanides such as metformin and phenformin, and thiazolidinediones (TZDs), rosiglitazone and pioglitazone, enhance AMPK signaling.</div></div>